Viatris Inc
VTRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001792044
No open-market purchases or sales by Viatris Inc insiders were filed in the last 90 days; 1,032 institutions reported holding it in 13F filings for Q2 2026, worth $16.6B in total; Greenlight Capital is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Viatris Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 1,010 | 15 | 1,003 | +8 |
| Shares | 964.2M | 2.48M | 977.9M | +16.2M (+1.7%) |
| Value | $11.5B | $29.6M | $10.4B | −$1.08B (−9.4%) |
15 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (89)
Institutions that held Viatris Inc at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (81)
Institutions that held Viatris Inc at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (15)
Institutions that held Viatris Inc at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 1,779,687 | $21.2M |
| Fjarde Ap-Fonden /Fourth Swedish National Pension Fund | 206,290 | $2.46M |
| Connectus Wealth, LLC | 183,116 | $2.19M |
| Grey Street Capital, LLC | 159,466 | $1.90M |
| Benedetti & Gucer, Inc. | 51,229 | $612.0K |
| Highlander Capital Management, LLC | 36,846 | $439.9K |
| Degroof Petercam Asset Management | 24,904 | $297.4K |
| Oracle Alpha Inc. | 15,425 | $184.2K |
| Imprint Wealth LLC | 14,015 | $167.3K |
| Cambridge Trust Co | 2,773 | $33.1K |
| Norwood Financial Corp | 1,220 | $14.6K |
| Retirement Group, LLC | 1,142 | $13.6K |
| Shell Asset Management Co | 432 | $5.00K |
| FSA Wealth Management LLC | 357 | $4.27K |
| Pflug Koory, LLC | 277 | $3.31K |